🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron Phase 2 weight loss data — 12 month update Page 5

Orforglipron Phase 2 weight loss data — 12 month update

JenPlateau Wed, Sep 11, 2024 at 8:13 PM 29 replies 2,118 viewsPage 5 of 6
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Sep 16, 2024 at 6:40 PM#21
Dr.PainCLE said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Coming at Dr.PainCLE’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Sep 16, 2024 at 7:40 PM
4 2julia.endo, JessicaM_2024, TomFromTexas and 1 other
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Sep 17, 2024 at 3:44 AM#22

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

5 3Dr.ObesityLA, NurseKim_ATL, paul_denver and 2 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Sep 17, 2024 at 12:47 PM#23

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

6 4mike_nyc, VendorMark, COA_Karl and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Sep 17, 2024 at 9:50 PM#24
lucas_SP_BR said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Last edited: Sep 18, 2024 at 12:50 AM
7 5gary_naperville, sean_dublin, hannah_MT and 4 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Sep 18, 2024 at 6:53 AM#25
lucas_SP_BR said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

Ask again with the specifics and you will get a better answer than this one.

8 6mike_nyc, VendorMark, COA_Karl and 5 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register